FY 2021 Results
RESEARCH AND DEVELOPMENT COSTS AND EXPENDITURES
STELLANTIS
RESULTS FROM CONTINUING OPERATIONS
€ million
H2 2021
H2 2020 (1)
H2 2020
Pro Forma (1)
FY 2021 (1)
FY 2020 (1)
FY 2021
Pro Forma (1)
FY 2020
Pro Forma (1)
Research and Development Expenditures Expensed
Amortization of Capitalized Development Expenditures
1,456
701
1,509
2,761
1,281
2,818
2,808
849
406
560
1,575
822
1,591
1,112
Impairment and Write-off of Capitalized Development
Expenditures
136
47
255
151
128
151
631
Total Research and Development Costs
2,441
1,154
2,324
4,487
2,231
4,560
4,551
Capitalized Development Expenditures (2)
1,492
661
1,812
2,976
1,199
3,055
3,402
Research and Development Expenditures Expensed
1,456
701
1,509
2,761
1,281
2,818
2,808
Total Research and Development Expenditures
2,948
1,362
3,321
5,737
2,480
5,873
6,210
(1)
Refer to Basis of Presentation for additional information regarding amounts presented for the respective period and additional information related to Pro Forma results included herein
(2) Does not include capitalized borrowing costs in accordance with IAS 23 - Borrowing costs (Revised)
February 23, 2022
FY 2021 RESULTS | 57View entire presentation